ALLMedicine™ Colposcopy Center
Research & Reviews 1,218 results
https://doi.org/10.1002/ijc.34120
International Journal of Cancer; Giorgi Rossi P, Ronco G et. al.
May 18th, 2022 - As the primary screening test, E6/E7 mRNA has shown similar sensitivity for CIN3+ and lower positivity rate than the HPV DNA test. Nevertheless, the overall mRNA positivity is too high for immediate colposcopy, making a triage test necessary. The ...
https://doi.org/10.1002/ijc.34117
International Journal of Cancer; Sauvaget C, Bazikamwe S et. al.
May 15th, 2022 - This longitudinal study aimed at evaluating the effectiveness, acceptability, and safety of the thermal ablation procedure (TA) in the treatment of cervical neoplasia. Women referred to the Gynaecology ward for symptoms or for opportunistic screen...
http://emedicine.medscape.com/article/253513-treatment
May 13th, 2022 - Approach Considerations Intravaginal application of 5% 5-fluorouracil (5-FU) was found to be an effective treatment for cervical intraepithelial neoplasia (CIN) 2 in a prospective, nonblinded, randomized controlled study of 60 women. [64, 65] At 6...
https://clinicaltrials.gov/ct2/show/NCT05092022
May 12th, 2022 - Patients will be recruited during their appointment at the PSH St. Joseph's residency clinic. If a patient is due for cervical cancer screening, they will be presented with the study letter that allows them to choose between (1) receiving the self...
https://doi.org/10.1097/LGT.0000000000000677
Journal of Lower Genital Tract Disease; Carcopino X, Cruickshank M et. al.
May 10th, 2022 - The aim of the study was to estimate the impact of COVID-19 pandemic on the practice of cervical cancer screening in European countries. A 3 rounds e-survey was conducted among the 31 European Federation for Colposcopy member countries during 2020...
Guidelines 19 results
https://doi.org/10.1097/AOG.0000000000003982
Obstetrics and Gynecology; Phianpiset R, Ruengkhachorn I et. al.
Aug 10th, 2020 - To compare the proportion of cervical intraepithelial neoplasia (CIN) 2 or worse pathology among different risk strata according to the ASCCP when applied in women who had atypical squamous cells of undetermined significance (ASC-US) or low-grade ...
https://doi.org/10.3322/caac.21628
CA: a Cancer Journal for Clinicians; Fontham ETH, Wolf AMD et. al.
Jul 31st, 2020 - The American Cancer Society (ACS) recommends that individuals with a cervix initiate cervical cancer screening at age 25 years and undergo primary human papillomavirus (HPV) testing every 5 years through age 65 years (preferred); if primary HPV te...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418593
International Journal of Gynecological Cancer : Official ... Ciavattini A, Delli Carpini G et. al.
Jun 4th, 2020 - European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic.|...
https://doi.org/10.1016/j.ajog.2020.02.029
American Journal of Obstetrics and Gynecology; Dempster-Rivett K, Innes CR et. al.
Feb 29th, 2020 - A high rate of regression in young women with cervical intraepithelial neoplasia grade 2 has been recorded. However, there are few prospective data by which to evaluate management guidelines. This study evaluates the American Society for Colposcop...
https://doi.org/10.1111/jog.14168
The Journal of Obstetrics and Gynaecology Research Refere... Bhatla N, Singhal S et. al.
Dec 10th, 2019 - In India, there are marked variations in resources for cervical cancer screening. For the first time, resource-stratified screening guidelines have been developed that will be suitable for low middle-income countries with similar diversities. The ...
Clinicaltrials.gov 91 results
https://clinicaltrials.gov/ct2/show/NCT05092022
May 12th, 2022 - Patients will be recruited during their appointment at the PSH St. Joseph's residency clinic. If a patient is due for cervical cancer screening, they will be presented with the study letter that allows them to choose between (1) receiving the self...
https://clinicaltrials.gov/ct2/show/NCT04746872
Apr 28th, 2022 - A prospective multicenter interventional study will be conducted to enroll women undergoing routine cervical cancer screening to collect cervical liquid-based cytology (LBC) specimen(s). For all subjects, two cervical specimens will be collected, ...
https://clinicaltrials.gov/ct2/show/NCT02328872
Apr 27th, 2022 - Compass is a randomised controlled trial of primary HPV testing for cervical cancer screening versus cytology screening in Australia. A pilot study involving 5,000 women was carried out in 2013-2014. The main trial will involve recruiting 76,300 w...
https://clinicaltrials.gov/ct2/show/NCT04687267
Apr 12th, 2022 - Women aged 25-45 years, adherent to the organized population-based cervical screening program, with a histological diagnosis of CIN2 and fulfilling the inclusion criteria will be invited to participate to the study, previously providing specific i...
https://clinicaltrials.gov/ct2/show/NCT04794660
Apr 8th, 2022 - The main objectives of CESTA are (1) to compare the efficacy of two cervical cancer screening algorithms: HPV test followed by visual inspection with acetic acid (VIA) and treatment (HPV + VIA + treat) and HPV test followed by immediate treatment ...
News 139 results
https://www.medscape.com/viewarticle/966639
Jan 17th, 2022 - Negative experiences of those receiving a diagnosis of cervical cell changes following screening have been highlighted in a new report from charity Jo’s Cervical Cancer Trust. Around 220,000 of the total screened population of about 3.5 million ar...
https://www.medscape.com/viewarticle/952345
Jun 3rd, 2021 - A better system of safety measures is needed to make sure patients are not mixed up and given the wrong invasive procedure during outpatient appointments, according to the latest report from the Healthcare Safety Investigation Branch (HSIB). The r...
https://www.onclive.com/view/cervical-cancer-screening-overuse-and-underuse-patient-and-physician-factors
Dec 5th, 2020 - Abstract Objectives: Despite recommendations for triennial cervical cancer screening for low-risk women aged 30 years and older, annual screening remains common. We studied how often women receiving care from an academically affiliated medical ...
https://www.onclive.com/view/articles_gr_oct2007
Dec 5th, 2020 - ITALY Coffee as a Prophylaxis Against Liver Cancer Even those drinking one cup of coffee each day seem to reap significant protection against hepatocellular cancer. Researchers from the Istituto di Ricerche Farmacologiche Mario Negri,...
https://www.onclive.com/view/clinical_abstracts_global
Dec 5th, 2020 - Click here to view as PDF. MULTIPLE SITES FROM AROUND THE WORLD Effects of Preoperative Radiotherapy on Quality of Life A randomized trial of 1350 patients with rectal cancer from Canada, New Zealand, South Africa, and the United Kingdom found ...